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Two independent studies by Li et al. (2010) and Samavarchi-Tehrani et al. (2010) in this issue ofCell StemCell
suggest that a mesenchymal-to-epithelial transition is a critical initiating event during the derivation of
induced pluripotent stem cells (iPSCs) from fibroblasts, indicating remarkable similarities between cellular
reprogramming, development, and cancer.Overexpression of the transcription
factors Oct4, Klf4, Sox2, and c-Myc
(OKSM) in somatic cells gives rise to
induced pluripotent stem cells (iPSCs)
that exhibit molecular and functional simi-
larities to embryonic stem cells (ESCs)
(Takahashi and Yamanaka, 2006). Thus,
iPSCs have great potential for the study
and possible treatment of numerous
degenerative diseases. The reprogram-
ming of fibroblasts is a slow (2–3 weeks)
and inefficient (<1%) process in which
somatic cells gradually lose their differen-
tiated identity and assume an embryonic
gene expression pattern and growth
behavior (Hochedlinger and Plath, 2009).
This conversion is accompanied by strik-
ing morphological changes as the cells
transition from a single layer of adherent
cells to become multilayered epithelial
cells, a process reminiscent of a mesen-
chymal-to-epithelial transition (MET).MET,
aswell as its reverseprocess, epithelial-to-
mesenchymal transition (EMT),playpivotal
roles during organ development and in
cancer metastasis by endowing cells with
migratory and invasive properties, respec-
tively (Thiery et al., 2009). In this issue of
Cell Stem Cell, the labs of Jeffrey Wrana
(Samavarchi-Tehrani et al., 2010) and
Duanqing Pei (Li et al., 2010) provide com-
pelling molecular and functional evidence
demonstrating thatMET is indeed a crucial
early phase during the reprogramming of
murine embryonic fibroblasts (MEF) into
iPSCs.
MET Occurs Early during
Reprogramming
When studying either gene expression
profiles (Samavarchi-Tehrani et al., 2010)
or morphological changes (Li et al.,2010) of MEFs during the initial stages of
reprogramming, the Wrana and Pei
groups uncovered striking cellular and
molecular similarities with the hallmarks
that define a MET. This pattern included
the upregulation of epithelial genes such
as E-cadherin and Epcam as well as the
concomitant downregulation of key
mesenchymal genes such as Snail and
N-Cadherin (Figure 1). Based on the
observed gene expression dynamics, Sa-
mavarchi-Tehrani and colleagues further
identified three consecutive phases of re-
programming, which they coined initia-
tion, maturation, and stabilization. The
MET-associated alterations were evident
during the initiation phase of reprogram-
ming, when cells are still dependent
on exogenous factor expression and
occurred before the subsequent matura-
tion and stabilization phases, when cells
activate an embryonic gene expression
program, suggesting that MET may be
one of the earliest changes fibroblasts
undergo during cellular reprogramming.
Dysregulation of MET Genes and
miRNAs Impair Reprogramming
The functional importance of the MET in
iPSC formation was shown by the Wrana
lab, who employed an RNAi screen (Sa-
mavarchi-Tehrani et al., 2010). This effort
identified several hairpins that abrogated
iPSC formation, including members of
theTGF-b superfamily suchasSmadsand
BMP receptors, which have previously
been implicated in MET (Thiery et al.,
2009). Consistent with these findings,
treatment of reprogramming cultures
with recombinant BMP-7 significantly in-
creased the number and accelerated the
speed of iPSC colony formation, whereasCell Stemexposure to the BMP antagonist Noggin
impaired colony formation. To identify
possible downstream effectors that may
be responsible for BMP’s ability to
enhance reprogramming, Wrana and
colleagues focused on the role of miRNA-
200 and miRNA-205, which have recently
been shown to control MET by downregu-
lating mesenchymal genes. Overexpres-
sion of these miRNAs in MEFs was indeed
sufficient to activate key MET genes in
combination with OKSM and gave rise to
SSEA1+ intermediate cells more rapidly
thancontrol cells. Intriguingly, overexpres-
sion of these miRNAs led to the rescue of
the inhibitory effect of knocking down
BMPs on iPSC formation, thus establish-
ing an epistatic link between extracellular
BMP signaling, miRNA-200 and miRNA-
205, and successful reprogramming.
Meanwhile, Li and colleagues (2010)
showed that E-Cadherin knockdown or
Snail overexpression, both of which inhibit
MET, substantially reduces the formation
of iPSCs. Further, under these conditions,
only dissociated epiblast-like colonies
with diminished growth and develop-
mental potentials arose, thus confirming
the functional importance of other key
effectors of the MET pathway during re-
programming. A clue as to how the re-
programming factors might synergize
with the MET pathway comes from the
observation that the E-cadherin promoter
is bound by Klf4, providing evidence for
the direct regulation of an MET-associ-
ated gene by one of the reprogramming
factors. Of note, Klf4 has been implicated
in the maintenance of epithelial tissues,
and thus may facilitate reprogramming
through exerting an epithelializing effect
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Figure 1. Fibroblast Reprogramming into iPSCs Entails
a Mesenchymal-to-Epithelial Transition
The initiation phase of reprogramming resembles amesenchymal-to-epithelial
transition (MET), generating unstable intermediate cells with epithelial charac-
teristics that revert into fibroblastic cells upon loss of OKSM expression (indi-
cated by dashed reverse arrow). The pluripotency network becomes activated
and solidified during the maturation and stabilization phases, respectively.
Shown are representative growth factors, miRNAs, and mesenchymal/epithe-
lial genes that influence MET and thus iPSC formation (see text for details).
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genes may control the main-
tenance of an epithelial char-
acter of pluripotent inner cell
mass cells because in vivo
downregulation of these
genes during development
correlates with the onset
of gastrulation and EMT.
Together, these data provide
strong functional evidence
that the manipulation of MET-
associated growth factors,
miRNAs, and cell adhesion
molecules enhance both re-
programming speed and
efficiency.
Epithelial Cells Are More
Amenable to
Reprogramming
Given that aMET seems to be
important during reprogram-ming, one would predict that epithelial
cells are more amenable to reprogram-
ming than mesenchymal cells. Indeed,
previous reports suggested that skin
keratinocytes, an epithelial cell type, give
rise to iPSCs more efficiently and faster
than fibroblasts (Aasen et al., 2008;
Maherali et al., 2008). Li et al. extended
these studies by showing that mammary
gland epithelial cells convert into iPSCs
more readily than fibroblasts. This popu-
lation expresses abundant endogenous
Klf4 and thus the cells do not require
ectopic expression of either c-Myc or
Klf4 to convert into iPSCs, further sup-
porting a role for these two factors in
conferring an epithelial phenotype on
mesenchymal cells. However, Klf4 seems
to play additional roles besides activating
E-Cadherin because the overexpression
of E-Cadherin alone could not compen-
sate for the function of Klf4 during iPSC
formation. It will certainly be interesting
to assess whether epithelial cells that do
not express Klf4 are equally amenable to
reprogramming by Oct4 and Sox2 alone.
TGF-b Inhibitors May Enhance
Reprogramming by Inducing a MET
The findings by Pei and Wrana may also
help to explain recent reports showing
that the treatment of fibroblasts with
TGF-b inhibitors enhances iPSC forma-
tion (Ichida et al., 2009; Lin et al., 2009;
Maherali and Hochedlinger, 2009). TGF-b
is a well-known inducer of EMT, which, in6 Cell Stem Cell 7, July 2, 2010 ª2010 Elsevilight of the current results, is expected to
inhibit reprogramming into iPSCs. Inter-
estingly, OKSM activation resulted in
reduced expression of TGF-b receptors
2 and 3 in MEFs and decreased secretion
of TGF-b1 into the media, suggesting that
the reprogramming factors counteract
this major EMT pathway. c-Myc expres-
sion alone appeared to be sufficient to
downregulate TGF-bR1 and TGF-bR2
expression, which the authors hypothe-
size might be how c-Myc activation
enhances reprogramming. In further sup-
port of this notion, the TGF-b receptor
inhibitor Alk5i substantially increased
reprogramming in the absence of c-Myc
but had less of an effect in the presence
of c-Myc (Ichida et al., 2009; Maherali
and Hochedlinger, 2009).
Concluding Thoughts
By using two complementary
approaches, the Wrana and Pei groups
conclusively demonstrate that MET is an
important rate-limiting step during the
conversion of fibroblasts into iPSCs. The
acquisition of an epithelial fate during
cellular reprogramming appears to be
tightly linked with the pluripotent state
and may reflect requirements for cell-cell
interactions that initiate and sustain pluri-
potency. The observation that epithelial
cells are more amenable to reprogram-
ming suggests that somatic cells with
pre-exisiting features of pluripotent cells
require fewer changes in order to reacher Inc.pluripotency. This notion is
consistent with previous find-
ings showing that immortal-
ized fibroblasts as well as
adult progenitors reprogram
at high efficiency into iPSCs,
presumably because these
cells already exhibit indefinite
growth potential and express
shared transcriptional or
epigenetic regulators, res-
pectively. Lastly, the pre-
sented studies underscore
the notion that both intracel-
lular as well as extracellular
factors impinge on somatic
cells during reprogramming.
An interesting question that
remains to be addressed is
whether nonmesenchymal
cell types such as blood cells
undergo MET-associated
changes as well or whetheralternative cellular processes need to be
initiated.
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